14.01.2022
11,467 reports of suspected adverse vaccination reactions evaluated
01.01.2022
Change in procedure for Project Orbis: Swissmedic information requests now to be sent exclusively to the applicant in Switzerland
01.01.2022
Simplification of the procedure for “ex officio" temporary authorisation
17.12.2021
10,842 reports of suspected adverse vaccination reactions evaluated
17.12.2021
Swissmedic supports the ICH’s ongoing development into a global initiative
16.12.2021
Healthcare professionals can now use their Healthcare Professional Identity (hp-id) to access ElViS
14.12.2021
The Consortium’s medicines regulators will only authorize medicines for COVID-19 if their clinical benefits outweigh their risks.
14.12.2021
(OMS-Organisations Management System)
13.12.2021
Swissmedic is issuing an urgent warning regarding slimming products and other supposedly natural products
10.12.2021
Comirnaty® approved for children aged 5 years and older – roughly a year after the initial authorisation for adults
06.12.2021
12 individual substances and one substance group added to the Narcotics List
02.12.2021
Ten years ago, Switzerland was one of the first states to sign the Medicrime Convention.
02.12.2021
Eingabefrist: 21. Januar 2022
26.11.2021
10,386 reports of suspected adverse vaccination reactions evaluated
24.11.2021
The seven-strong Agency Council is Swissmedic's supervisory body
05.11.2021
9,834 reports of suspected adverse vaccination reactions evaluated
01.11.2021
The new guidance document is valid with effect from 1 November 2021.
19.10.2021
Vaccine candidate CVnCoV no longer in rolling review procedure
